Letter to FDA

9/11/2017
AUTM joined other organizations to comment on the July 18, 2017 public meeting on the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act (FD&C Act).
 
AUTM joined the Association of American Medical Colleges (AAMC), Association of American Universities (AAU), Association of Public Land-grant Universities (APLU) and the Council On Governmental Relations (COGR) in a letter to Dr. Scott Gottlieb, Comissioner of Food and Drugs at the U.S. Food and Drug Administration.

The organizations expressed their concern "that recent comments made at this meeting about the Bayh-Dole Act’s 'march-in' rights provision misinterpret the statutory language of the Act, as well as Congress’ original intent. If the applicable scope of march-in rights is broadened beyond Congress’ original intent, the private sector likely will be hesitant or unwilling to license federally funded inventions from universities, impeding progress against some of our costliest and most challenging diseases to the detriment of public health and safety."

Read the full letter.